Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ ...

Technological advancements in synthetic chemistry, bioproduction, and containment are enhancing the feasibility of developing ...

Eli Lilly plans API plant in Alabama to produce small molecule and peptide medicines, creating 450 jobs and enhancing U.S. pharmaceutical supply chains.

This article is the second installment in our three-part series, Artificial Intelligence as Intellectual Property or “AI as IP™”, which explores ...

Large pharmaceutical conglomerate Eli Lilly has announced plans to build a $6 billion manufacturing facility in Huntsville, Alabama. The site will focus on the production of small molecules and ...

Agentic AI marks a major evolution in artificial intelligence, moving beyond reactive tools to autonomous systems that can ...

Eli Lilly and Company today announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. This next-generation synthetic medicine active pharmaceutical ...

MESA, ARIZONA / ACCESS Newswire / December 3, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to highlight its strategic advantage of operating as a lean, agile company in the ...

Back in August, the FDA announced that it was working on a new program dubbed FDA PreCheck, which broadly aims to improve ...

Cyber A.I. Group, Inc. ("CyberAI" or the "Company"), an emerging growth Cybersecurity, Artificial Intelligence and IT services company engaged in the development of next-generation market disruptive ...

Baystreet.ca News Commentary – The artificial intelligence in healthcare market is projected to expand from $17.2 billion in 2025 to $77.2 billion by 2035 as digital transformation and ...

AI in Healthcare Regulatory Affairs Market to reach USD 6.5 Bn by 2035 at 16.7% CAGR, driven by rising regulatory complexity and AI adoption.